Ultrasound-guided fine-needle aspiration for retrojugular lymph nodes in the neck by Dong Kim
WORLD JOURNAL OF 
SURGICAL ONCOLOGY 
Kim World Journal of Surgical Oncology 2013, 11:121
http://www.wjso.com/content/11/1/121RESEARCH Open AccessUltrasound-guided fine-needle aspiration for
retrojugular lymph nodes in the neck
Dong Wook KimAbstract
Background: No study on ultrasound-guided fine-needle aspiration (US-FNA) for the diagnosis of retrojugular
lymph node has been reported. The present study aimed to introduce US-FNA techniques for retrojugular lymph
node and to evaluate their efficacy.
Methods: Of the 788 patients who underwent US-FNA of the cervical lymph node, 41 patients underwent US-FNAs
of retrojugular lymph node and were included in this study. The adequacy and efficacy of US-FNA of retrojugular
lymph node and related complications during or after the procedure were assessed.
Results: Of the 41 patients, 35 (85.4%) were adequately diagnosed in cytological analysis; four predominantly cystic
lymph nodes were identified. Based on cytohistopathology results, thyroglobulin measurement, tuberculosis
polymerase chain reaction, and sonographic follow-up, malignant (n = 26) and benign (n = 15) lymph nodes were
confirmed. When six lymph nodes with inadequate cytology were classified as benign and malignant, the
sensitivity, specificity, positive and negative predictive values, and accuracy of US-FNA in differentiating malignant
from benign lesions were 69.2% and 92.3%, 100% and 100%, 100% and 100%, 65.2% and 88.2%, and 80.5% and
95.1%, respectively. No substantial complications related to the US-FNA procedure were observed.
Conclusions: The present US-FNA method may be helpful for the diagnosis of retrojugular lymph node.
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Fine-needle aspiration (FNA) is widely accepted as an
effective method for diagnosing nodular lesions in the
head and neck [1-6]. The diagnostic accuracy of FNA
for diagnosing lymph node metastasis in the neck ranges
from 91% to 100% [7-9], and the most common primary
malignancies involving the cervical lymph node are
squamous cell carcinoma and papillary thyroid carcin-
oma [5]. Recently, analysis of the tumor marker concen-
tration in the FNA washout has been found to improve
the detection of lymph node metastasis in patients with
known malignancies [10].
FNA is used worldwide as a first-line method for the
diagnosis of palpable neck masses or lymph nodes, but
ultrasound-guided FNA (US-FNA) can additionally be
used to assess non-palpable or less palpable neck masses
or lymph nodes. However, in some cases, US-FNA ofCorrespondence: dwultra@lycos.co.kr
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reproduction in any medium, provided the orneck mass or lymph node involves a difficult approach.
In particular, US-FNA for neck masses or lymph nodes
that are located behind major vessels is difficult, even
for experienced practitioners. This procedure may be
performed by directly puncturing the major vessel after
compressing the major vessel with the US probe, but it
carries a risk of inducing tumor seeding through the
major vessel. To the best of my knowledge, no report
has presented or recommended US-FNA sampling of a
lymph node hidden by the internal jugular vein (called
retrojugular lymph node).
The present study describes US-FNA techniques for
retrojugular lymph nodes, and the adequacy and efficacy
of US-FNA of retrojugular lymph node and related com-
plications were assessed.Methods
Patients
The study was approved by the Institutional Review Board
(IRB 12-004). From January 2008 to December 2010,is an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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patients (female: male = 565:223; mean age, 45.8 years;
age range, 1 to 85 years) at our hospital. Among them,
consecutive patients who underwent US-FNA of a retro-
jugular lymph node were selected for this study. Before
US-FNA, all study patients were screened by a diagnostic
neck US examination using a high-resolution ultrasound
scanner (iU 22; Phillips Medical Systems, Bothell, WA,
USA) with a 5- to 12-MHz linear probe. All US-FNAs
were performed by a single radiologist with 8 years of
experience.
The criteria for a patient to undergo US-FNA of a
retrojugular lymph node included (1) the presence of a
retrojugular lymph node with likely malignancy or tuber-
culous lymph node, as determined by diagnostic US; (2) the
absence of an alternative, non-retrojugular lymph node
with likely malignancy or tuberculous lymph node.
Ultrasound-guided fine-needle aspiration of the
retrojugular lymph node
The assay was performed with a 10-ml plastic syringe
attached to a conventional 23-gauge needle without an
aspiration device. The patients were placed in the supine
position and the exact position was decided according to
the location of target node. For right retrojugular lymph
node, the practitioner sat on the left side of the patient,
facing the patient’s feet, because the practitioner was
right-handed. For left retrojugular lymph node, the prac-
titioner sat on the right side of the patient, facing the
patient’s face. After the patient’s neck was sterilely
prepared and draped, the target node was localized in
the center of the US monitor using the US probe. Du-
ring the entire procedure, the practitioner maneuvered
the US probe in his left hand and the syringe-needle unit
in his right hand. This positioning allowed the practi-
tioner’s thumb to control the power of syringe aspiration
by retracting the piston of the syringe. To prevent the
direct puncture of major vessels, the practitioner intro-
duced the tip of the needle away from the lateral wall of
the internal jugular vein (Figure 1). Before needle punc-
ture, it was helpful to visualize the motion of the tissue
on the US monitor when the needle was gently moved
back and forth on the skin surface. A shallow, perpen-
dicular puncture was made several millimeters away
from the lateral wall of internal jugular vein. After per-
pendicularly introducing the needle tip to the level of
the posterior wall of the internal jugular vein, the practi-
tioner laterally angulated the syringe-needle unit until
the needle tip was facing toward the target. The target
lesion was then kept centered in the transverse US
image, and the practitioner advanced the needle into the
target lymph node using an oblique puncture technique.
With real-time monitoring on the US monitor, the nee-
dle tip could then be positioned within an appropriatearea of the target. It was particularly important to thor-
oughly monitor the needle tip during the entire proced-
ure. After the needle tip was placed in the appropriate
position within the target, the sampling commenced
using back-and-forth movements and a mixed sampling
technique (that is, capillary sampling at first, followed by
gradual aspiration). No local anesthesia was used in US-
FNA for any patient.
Following US-FNA, each sample was immediately
mounted onto a glass slide. In each US-FNA, the practi-
tioner could obtain 4 to 6 slides by duplicating the
smears from one needle pass and one-sampling. The
slides were fixed in 95% ethanol and then sent for
cytological analysis. For partially cystic lesions, the
remaining aspirate within the syringe was sent for cell
analysis, thyroglobulin titers, or tuberculosis polymerase
chain reaction according to the clinico-sonographic indi-
cation. Electrochemiluminescent immunoassay using the
Elecsys automatic system (Roche, Mannheim, Germany)
was used for measurement of thyroglobulin titer from
aspirates in US-FNA. Any patient complication that oc-
curred during or after the US-FNA procedure was also
recorded.
Assessment of the final diagnosis for retrojugular lymph
node
The assessment criteria for the final diagnosis of retro-
jugular lymph node included (1) histopathology results;
(2) the presence of confirmative cytology findings, in-
cluding typical papillary thyroid carcinoma or squamous
cell carcinoma; (3) tuberculosis polymerase chain reac-
tion results; (4) in aspirates, when the thyroglobulin titer
of the retrojugular lymph node is >1,000 ng/ml or is 10-
fold higher than the serum thyroglobulin level, it is cla-
ssified as a metastatic lymph node from papillary thyroid
carcinoma; and (5) when a retrojugular lymph node shows
no malignant cytohistopathology, a negative thyroglobulin
titer in aspirates, and no malignant finding in the initial
and follow-up USs, it is classified as benign.
Statistical analysis
The incidence of all retrojugular lymph nodes was statis-
tically evaluated with regard to sex, age, and location
using Fisher’s exact test. The adequacy of US-FNA
for retrojugular lymph nodes was statistically evaluated
depending on the largest diameter of the lymph node
(≥10 mm and <10 mm) using Fisher’s exact test. The
sensitivity, specificity, positive and negative predictive
values, accuracy, and false positive and negative rates of
US-FNA for the retrojugular lymph nodes were cal-
culated by comparing the US-FNA results with the final
results. For this analysis, lymph nodes showing in-
adequate cytology were classified as either benign or ma-
lignant. These data were evaluated using Fisher’s exact
Figure 1 A 48-year-old woman with a retrojugular lymph node in left side of neck on follow-up ultrasound (US) after total thyroidectomy
for papillary thyroid carcinoma (4.1 × 5.3 × 5.5 mm). The retrojugular lymph node was diagnosed as ‘lymph node metastasis from papillary
thyroid carcinoma’ in cytology after US-FNA, and the patient underwent radioisotope therapy without neck surgery. A. Perpendicular puncture: a
spot away from the lateral wall of the internal jugular vein. B. Lateral angulation of the syringe-needle unit (the echogenic line (arrows) indicates
the needle shaft and tip). C. A successful puncture of the target after an appropriate approach of the syringe-needle unit (the echogenic line
(arrows) indicates the needle shaft and tip). D. Drawings illustrating how to approach a lymph node located in the retrojugular area. Initially, the
needle is perpendicularly inserted at the periphery of the internal jugular vein (left). The syringe-needle unit is then angled and the needle tip is
wedged into the lesion (middle and right).
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nificant. Data analyses were performed with SPSS for
Windows (version 17.0.1; SPSS Inc., Chicago, IL, USA).Results
During the study period, 41 patients (female: male = 36:5;
mean age, 44.2 years; age range, 22 to 65 years) underwent
US-FNA of retrojugular lymph node (mean size, 9.2 mm;
size range, 5 to 25.3 mm) because of a clinical or sono-
graphic suspicion of malignant (n = 39) or tuberculous
(n = 2) lymph node. Only one sampling was used for all
US-FNAs, and 4 predominantly cystic lymph nodes were
found in the diagnostic US. Retrojugular lymph node was
located on the right (n = 23) and left (n = 18). There was
no significant difference in the incidence of retrojugular
lymph node according to age, sex, and location (P >0.05,
Fisher’s exact test). Of the 41 patients, 35 (85.4%)
showed adequate cytology in US-FNA of retrojugular
lymph node. The diagnostic adequacy of US-FNA did
not differ between retrojugular lymph nodes with thelargest diameter ≥10 mm and those with the largest
diameter <10 mm (P = 0.1336, Fisher’s exact test).
Of 39 suspicious malignant lymph nodes, histories of
malignancy in the thyroid (n = 36), lung (n = 1), gastro-
intestinal tract (n = 1), and ovary (n = 1) were found. Based
on the cytohistopathological results (n = 26), thyroglobulin
titers (n = 5), tuberculosis polymerase chain reaction
(n = 2), and long-term US follow-up (n = 8), 26 malignant
and 15 benign lymph nodes were finally determined. The
sonographic diagnoses, cytological analyses in US-FNA,
and final diagnoses in the 41 retrojugular lymph nodes are
summarized in Table 1. The retrojugular lymph nodes in
ten patients were surgically removed and among them, six
were thyroid cancers (five papillary thyroid carcinomas and
one medullary thyroid carcinoma); one was lung cancer
(squamous cell carcinoma); one was ovarian cancer (poorly
differentiated carcinoma); and two were reactive hyper-
plasias. The non-surgical retrojugular lymph nodes in 31
patients included 17 thyroid cancers (papillary thyroid
carcinoma) and 14 reactive hyperplasias, and 17 patients
with thyroid cancer underwent only radioisotope therapy.
Table 1 Sonographic diagnosis, cytological result in ultrasound-guided fine-needle aspiration (US-FNA), and final
diagnosis in 41 retrojugular lymph nodes
Sonographic diagnosis (n) Cytological result (n) Final diagnosis (n)
Indeterminate for malignancy (15) Benign (13), suspicious for malignancy (2) Metastasis from ovarian cancer (1),
metastasis from PTC (2), RH (12)
Lymph node metastasis from thyroid
malignancy (22)
Inadequate (6), benign (1), suspicious
for malignancy (1), malignant (14)
Metastasis from PTC (21),
metastasis for MTC (1)
Lymph node metastasis from non-thyroid
malignancy (2)
Benign (1), suspicious for malignancy (1) Metastasis from lung cancer (1), RH (1)
Tuberculous lymph node (2) Benign (2) RH (2)
Total (41)
MTC medullary thyroid carcinoma, PTC papillary thyroid carcinoma, RH reactive hyperplasia.
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as benign and malignant, which included four predomin-
antly cystic lymph nodes and two solid lymph nodes, the
sensitivity, specificity, positive and negative predictive
values, and accuracy of US-FNA in differentiating malig-
nant from benign lesions were 69.2% and 92.3%, 100%
and 100%, 100% and 100%, 65.2% and 88.2%, and 80.5%
and 95.1%, respectively (Table 2). All 6 lymph nodes
with inadequate cytology were confirmed as metastatic
nodes from papillary thyroid carcinoma.
No substantial complications were observed for US-
FNA of retrojugular lymph node, except for several cases
of mild pain (5/41, 12.2%). The patients complaining of
mild pain during or after the procedure did not take
analgesics. No specific abnormality related to US-FNA
was reported in the biopsy site on follow-up US over a
6-month period in any patient.
Discussion
US-FNA for head and neck lesions is widely used because
it is inexpensive, rapid, well accepted by patients and has a
high diagnostic accuracy [5]. However, FNA for the initial
diagnosis of primary malignant lymph node remains
controversial because of its questionable accuracy for the
diagnosis of nodal involvement of lymphoma or leukemia
[8,11-13]. Nevertheless, US-FNA for the cervical lymph
node is used as a first-line diagnostic tool because
most malignant lymph nodes are metastatic rather thanTable 2 Diagnostic index of ultrasound-guided fine-needle as







False positive rate 0/15(0)
False negative rate 8/26(30.8)
NPV negative predictive value, PPV positive predictive value.primary. In patients with a history of malignancy, FNA
showed a high sensitivity because it only needs to evaluate
whether malignant cells are present or not; the disadvan-
tages of FNA include a high rate of nondiagnostic samples
and false-negative results [14].
In the present study, the most common site of the pri-
mary malignancy was the thyroid (36/41, 87.8%), and the
mean size of the retrojugular lymph nodes was 9.2 mm.
The high incidence of retrojugular lymph node metastasis
from primary papillary thyroid carcinoma cannot be
explained at present. Despite the small size of retrojugular
lymph nodes, US-FNA provided a good adequacy (35/41,
87.5%) and diagnostic accuracy (33/35, 94.3%). In addition,
there was no significant effect of the node size (≥10 mm
or <10 mm) on the adequacy of US-FNA for retrojugular
lymph node. Because of the presence of malignant cystic
lymph node (n = 4), the diagnostic accuracy of US-FNA
for retrojugular lymph node was higher when six nodules
showing inadequate cytology were considered to represent
malignancy or excluded from the calculation than when
they were considered to be benign.
The author did not prefer US-FNA for retrojugular
lymph node as shown in the inclusion criteria. US-FNA
for retrojugular lymph node was not performed when
non-retrojugular lymph node could be substituted for
retrojugular lymph node. In addition, the author has
performed US-FNA for the cervical lymph node with the
largest diameter of >5 mm. However, some practitionerspiration (US-FNA) for 41 retrojugular lymph nodes
tology
(%)
Inclusion of inadequate cytology
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to be ≥10 mm. Regardless of the cutoff diameter, the
author emphasizes that the most important factor for suc-
cessful US-FNA of retrojugular lymph node is complete
monitoring, to accurately determine the position of the
needle tip under US guidance.
There are several limitations to the present study.
First, of the 41 retrojugular lymph nodes, only 10 were
surgically confirmed. Second, there was a high rate of
primary thyroid malignancy (87.8%, 36/41), which may
represent a bias. Third, of the 36 patients with a history
of thyroid malignancy, only 9 (25%) underwent thyro-
globulin measurement for FNA aspirates. Furthermore,
tumor marker concentration in FNA washout was not an-
alyzed. Finally, a single experienced radiologist performed
US-FNA in all cases. For further clarification, a multicen-
ter study may be required.
Conclusions
The present study showed a good adequacy and accuracy
in US-FNA of retrojugular lymph nodes and no substantial
complications. Therefore, the present US-FNA method
may be helpful for the diagnosis of retrojugular lymph
nodes.
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